| Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness (NCT04011280) | University of California, San Diego | 2019-08-12 |
| A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging (NCT04038957) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-08-07 |
| A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder (NCT04030143) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-08-01 |
| Imaging Synapses With [11C] UCB-J in the Human Brain (NCT04038840) | Davidzon, Guido, M.D. | 2019-08-01 |
| Prebiotic Treatment in People With Schizophrenia - Pilot Study (NCT03617783) | University of Maryland, Baltimore | 2019-07-18 |
| Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia (NCT03999190) | NYU Langone Health | 2019-07-01 |
| Maximizing the Impact of Neuroplasticity Using Transcranial Electrical Stimulation Study 2 (NCT03896438) | University of Minnesota | 2019-07-01 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone (NCT03978832) | Indivior Inc. | 2019-06-28 |
| Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia (NCT03817502) | Gedeon Richter Plc. | 2019-06-06 |
| Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment (NCT04002258) | Shanghai Mental Health Center | 2019-06-06 |
| Peer Support Experience for Patients Discharged From Acute Psychiatric Care (NCT03404882) | University of Alberta | 2019-06-01 |
| Cognitive Remediation for Coordinated Specialty Care (NCT03930251) | New York State Psychiatric Institute | 2019-06-01 |
| Comparison of Ketamine Combine Propofol vs Propofol Anesthesia in Schizophrenia Electroconvulsive Therapy (NCT03829124) | Chang Gung Memorial Hospital | 2019-05-24 |
| Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia (NCT04010305) | BioXcel Therapeutics Inc | 2019-05-22 |
| Effects of Brain Stimulation on Higher-Order Cognition (NCT03814967) | University of California, Davis | 2019-05-22 |
| Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia (NCT03838484) | Vanderbilt University Medical Center | 2019-05-10 |
| tDCS, Stress and Risk for Schizophrenia (NCT03217357) | Hôpital le Vinatier | 2019-05-02 |
| Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia (NCT03648268) | Beth Israel Deaconess Medical Center | 2019-05-02 |
| Cognitive Enhancement on Working Memory in Patients With Schizophrenia (NCT03872310) | Taipei Medical University Shuang Ho Hospital | 2019-05-01 |
| Adapting Critical Time Intervention to Support Inpatient Medical Care Transition (NCT03637296) | New York State Psychiatric Institute | 2019-05-01 |
| A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite® (NCT03892889) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-04-29 |
| Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI) (NCT03873337) | Rutgers, The State University of New Jersey | 2019-04-22 |
| Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms (NCT03929497) | H. Lundbeck A/S | 2019-04-22 |
| Intervention Targeting Motivational Negative Symptoms (NCT04325100) | University of Liege | 2019-04-20 |
| Pentoxifylline Add-on Therapy for Schizophrenia (NCT05073640) | Mazra Mental Health Center | 2019-04-20 |
| A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia (NCT03893825) | Teva Branded Pharmaceutical Products R&D, Inc. | 2019-04-17 |
| Effectiveness of A Stigma Directed Interventional Program in Schizophrenia (NCT03930225) | Mansoura University | 2019-04-16 |
| This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia (NCT03859973) | Boehringer Ingelheim | 2019-04-15 |
| Psychometric Validation of an Oral Health-related Scale for Quality of Life and Coping in People With Schizophrenia (NCT03699501) | Centre Hospitalier Universitaire Dijon | 2019-04-15 |
| Efficacy of Metacognitive Training for Schizophrenia - a Study Protocol (NCT03891186) | University Rovira i Virgili | 2019-04-15 |
| Role of Vitamin D Supplementation in Schizophrenia (NCT03101319) | Central Institute of Psychiatry, Ranchi, India | 2019-04-08 |
| Cognitive Adaption Training-Effectiveness in Real-world Settings and Mechanism of Action (CAT-EM) (NCT03829280) | The University of Texas Health Science Center at San Antonio | 2019-04-04 |
| DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole (NCT03881449) | Durham VA Medical Center | 2019-04-04 |
| Research of Anatomo-functional Biomarkers in Schizophrenia (NCT03996122) | University Hospital, Caen | 2019-04-04 |
| The Effect of Psychoeducation on Healthy Lifestyle Behaviors in Individuals With Schizophrenia (NCT05259748) | Hatay Training and Research Hospital | 2019-04-01 |
| Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia (NCT03794076) | Vishwajit Nimgaonkar, MD PhD | 2019-04-01 |
| Modulation of Repetitive Transcranial Magnetic Stimulation on Hippocampal Neurogenesis and Functional Network in Patients With Schizophrenia (NCT03608462) | Shanghai Mental Health Center | 2019-04-01 |
| The Effect of Psychoeducation Based on Uncertainty In Illness Theory On Schizophrenia Caregivers (NCT04822051) | Akdeniz University | 2019-04-01 |
| Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS) (NCT03919994) | Alkermes, Inc. | 2019-03-28 |
| Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder (NCT03872596) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-03-27 |
| Mobile CBT for Negative Symptoms (NCT03621774) | University of California, San Diego | 2019-03-27 |
| Improving Visual Attention in Schizophrenia (NCT03880227) | The University of Texas at Dallas | 2019-03-25 |
| Overcoming Psychomotor Slowing in Psychosis (OCoPS-P) (NCT03921450) | University of Bern | 2019-03-25 |
| D-serine Augmentation of Neuroplasticity (NCT03711500) | New York State Psychiatric Institute | 2019-03-13 |
| EEG-based Neurofeedback for Auditory Verbal Hallucinations (HALFEED) (NCT03852706) | University of Dublin, Trinity College | 2019-03-01 |
| Treating Smokers With Mental Illness (NCT03822416) | University of Minnesota | 2019-03-01 |
| ITI-007 (Lumateperone Tosylate) for Schizophrenia (NCT03817528) | New York State Psychiatric Institute | 2019-03-01 |
| Anti-inflammatories and Adolescent Schizophrenia (NCT04020588) | Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico | 2019-02-25 |
| Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia (NCT03896945) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-02-15 |
| Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness (NCT03935854) | Stanford University | 2019-02-13 |
| Verbal Memory Training Using Virtual Reality in Schizophrenia (NCT04251195) | The Royal Ottawa Mental Health Centre | 2019-02-12 |
| Enhancement of Treatment of Delusions in Schizophrenia Through Neuromodulation (NCT03062553) | University of British Columbia | 2019-02-01 |
| Telmisartan Pilot Study on Treatment Resistant Schizophrenia (NCT03868839) | Xiaoduo Fan | 2019-02-01 |
| A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder (NCT03854409) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2019-01-31 |
| The Efficacy of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia (NCT03772951) | Shanghai Mental Health Center | 2019-01-10 |
| Effects of Aerobic Exercise, Cognitive Remediation and Combined Intervention in Schizophrenia (NCT06810362) | IRCCS San Raffaele | 2019-01-10 |
| Multicenter, Randomized, Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolar I Disorder or Schizoaffective Disorder (NCT03630822) | Assistance Publique Hopitaux De Marseille | 2019-01-02 |
| Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia (NCT04094207) | Sadat City University | 2019-01-01 |
| Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder. (NCT03510741) | Pakistan Institute of Living and Learning | 2019-01-01 |
| Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates (NCT03495024) | Corporal Michael J. Crescenz VA Medical Center | 2019-01-01 |
| Salutogenic Approach Based Interview With People With Schizophrenia (NCT04740944) | Istanbul University - Cerrahpasa | 2018-12-31 |
| Multi-component Intervention for Diabetes in Adults With Serious Mental Illness (NCT03627377) | University of California, San Diego | 2018-12-28 |
| A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients (NCT03751488) | Luye Pharma Group Ltd. | 2018-12-12 |
| Study of Efficacy of PEAR-004 in Schizophrenia (NCT03751280) | Novartis Pharmaceuticals | 2018-12-10 |
| Cannabis and Thought Disorder in Schizophrenia (NCT03608137) | Hôpital le Vinatier | 2018-12-07 |
| Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life (NCT03757988) | University of North Carolina, Chapel Hill | 2018-12-06 |
| Influence of rTMS on Symptoms and Cognitive Function in Patients With Psychiatric Disorders (NCT04055181) | Beijing HuiLongGuan Hospital | 2018-12-01 |
| Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With Schizophrenia (NCT03437668) | Chengappa, K.N. Roy, MD | 2018-12-01 |
| Neurophysiological Evaluation of Schizophrenia Patients After Cognitive and Physical Intervention (NCT03899662) | Aristotle University Of Thessaloniki | 2018-11-30 |
| A Study for Schizophrenia Relapse Prediction (NCT03629951) | Janssen Research & Development, LLC | 2018-11-29 |
| A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly (NCT03809325) | Janssen-Cilag International NV | 2018-11-21 |
| Childhood Trauma in Schizophrenia: Exploration of Links Between Gene Expression, Cerebral Morphology and Symptomatology (NCT03355781) | Centre Hospitalier Universitaire de Saint Etienne | 2018-11-14 |
| CVN058 Effect on Mismatch Negativity in Schizophrenics (NCT03669250) | Cerevance Alpha, Inc. | 2018-11-09 |
| 18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia (NCT06880328) | Hoffmann-La Roche | 2018-11-07 |
| OnTrack>An Online Role-Playing Game for Young People With First Episode Psychosis (NCT03390491) | Center for Social Innovation, Massachusetts | 2018-11-01 |
| Motivation and Skills Support (MASS) (NCT03404219) | Boston University Charles River Campus | 2018-11-01 |
| Transcranial Alternating Current Stimulation (tACS) for Cognitive Impairments in Patients With Schizophrenia (NCT03756610) | Shanghai Mental Health Center | 2018-11-01 |
| Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functional Magnetic Resonance Imaging (fMRI) Studies of Schizophrenia and Depression (NCT03758495) | VA Office of Research and Development | 2018-11-01 |
| Cognitive Remediation Therapy for Participants With Late-Life Schizophrenia (NCT03695614) | Centre for Addiction and Mental Health | 2018-10-24 |
| Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia (NCT04038788) | Tri-Service General Hospital (TSGH) | 2018-10-24 |
| Effects of Narrative Enhancement and Cognitive Therapy (NECT) on Self-stigma in Patients With Schizophrenia (NCT03967431) | National Yang Ming Chiao Tung University | 2018-10-20 |
| Circuitry-Guided Smoking Cessation in Schizophrenia (NCT03281629) | University of Maryland, Baltimore | 2018-10-19 |
| A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities (NCT03713658) | Janssen Research & Development, LLC | 2018-10-18 |
| Brain Stimulation and Cognitive Training (NCT03338673) | University of Michigan | 2018-10-11 |
| Planning Your Everyday Life in Virtual Reality : a Study in Schizophrenia; (NCT04011774) | Centre Hospitalier St Anne | 2018-10-09 |
| Cognitive Effects of Nimodipine in Patients With Schizophrenia (NCT03671525) | Johns Hopkins University | 2018-10-05 |
| Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia (NCT04411979) | Chang Gung Memorial Hospital | 2018-09-27 |
| A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia (NCT03697252) | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2018-09-18 |
| Mindfulness and Cognition in Schizophrenia (NCT03318640) | Centre Hospitalier Universitaire de Saint Etienne | 2018-09-11 |
| Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy (NCT03652974) | Shanghai Mental Health Center | 2018-09-06 |
| Integrated Care (IC) Models for Patient-Centered Outcomes (NCT03451630) | University of Pittsburgh | 2018-09-04 |
| D-serine in Schizophrenia (NCT03702933) | Herzog Hospital | 2018-09-01 |
| Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals (NCT03790085) | Tianjin Medical University General Hospital | 2018-09-01 |
| PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia (NCT03285503) | Otsuka Beijing Research Institute | 2018-08-17 |
| Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia (NCT03034356) | VA Office of Research and Development | 2018-08-15 |
| A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal (NCT03666715) | Janssen-Cilag Farmaceutica Ltda. | 2018-08-07 |
| Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia (NCT03593213) | AbbVie | 2018-07-30 |
| tDCS and Cognitive Training Intervention for Chronic Smokers With Schizophrenia (NCT03588728) | University of Pittsburgh | 2018-07-23 |
| Effects of Oxytocin on Negative Symptoms and Social Cognition in Schizophrenia and Its Possible Mechanisms (NCT03662425) | Shanghai Mental Health Center | 2018-07-21 |
| Improving Accessibility and Personalization of CR for Schizophrenia (NCT03576976) | New York State Psychiatric Institute | 2018-07-16 |